CD Genomics enjoys a high reputation for sequencing, microarray analysis, library construction and genotyping, providing reliable services to pharmaceutical and biotechnology companies as well as academia and government agencies. Based on rich experience in targeted sequencing, CD Genomics has developed a specialized platform for targeted sequencing of disease-related genes to accelerate research on disease pathogenesis, disease identification, biomarker discovery, targeted drug development, etc. CD Genomics offers predesigend NGS panels, which include a designed library of targeted sequencing, as well as a custom panel that allows customers to select genes of interest to design their own sequencing panels.

OUR VISION

To be the most trusted partner with pharmaceutical and biotechnology companies as well as academia and government agencies for Disease Targeted Sequencing.

OUR MISSION

Submit a high quality, high accuracy report on gene variants to our customer.

PERSONALIZATION

We provide custom panels for mutation detection. The genes we can detect are not limited to the reference genes we have listed. As long as you have the genes of interest, you are welcome to contact us. We will give you a satisfactory answer after discussion.

MORE PROJECT

Dedicated Teams

Experienced

Flexibility for Effctive and Efficient Execution

Seamless Integration from Samples to Reports

One Stop Service

State-of-the-art Facilities

  • 45-1 Ramsey Road, Shirley, NY 11967, USA
  • 1-631-275-3058 (USA)
           44-208-144-6005 (Europe)
  • 1-631-614-7828
  • info@cd-genomics.com
Copyright © 2009 - 2020 CD Genomics. All rights reserved.
0
Inquiry Basket